Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-19

Clinical Trial Update: Cannabidiol for Alcohol Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating cannabidiol for Alcohol Use Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Use Disorder | Phase 1, Phase 2 | Status: WITHDRAWN